<!DOCTYPE HTML>
<!--
	TXT by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title>No Sidebar - TXT by HTML5 UP</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1" />
		<!--[if lte IE 8]><script src="assets/js/ie/html5shiv.js"></script><![endif]-->
		<link rel="stylesheet" href="assets/css/main.css" />
		<!--[if lte IE 8]><link rel="stylesheet" href="assets/css/ie8.css" /><![endif]-->
	</head>
	<body>
		<div id="page-wrapper">

			<!-- Header -->
				<header id="header">
					<div class="logo container">
						<div>
							<h1><a href="index.html" id="logo">TXT</a></h1>
							<p>A responsive site template by HTML5 UP</p>
						</div>
					</div>
				</header>

			<!-- Nav -->
				<nav id="nav">
					<ul>
						<li class="current"><a href="index.html">Home</a>
							<ul>
								<li><a href="#">Welcome Letter</a></li>
								<li><a href="#committees">Committees</a></li>
								<li><a href="#Congress Floor Plan">Congress Floor Plan</a>
								<li><a href="#Timetable">Timetable</a>
								<li><a href="#Poster Overview">Poster Overview</a>
									<ul>
										<li><a href="#">Poster Presenters</a></li>
										<li><a href="#e-posters">E-Posters</a></li>
										<li><a href="#">Poster Map</a></li>
									</ul>
							</ul>
						</li>
						<li><a href="Sunday.html">Sunday</a></li>
						<li><a href="Monday.html">Monday</a></li>
						<li><a href="Tuesday.html">Tuesday</a></li>
						<li><a href="Wednesday.html">Wednesday</a></li>
						<li><a href="Thursday.html">Posters</a>							
						<ul>
								<li><a href="#">Monday</a></li>
								<li><a href="#">Tuesday</a></li>
								<li><a href="#">Wednesday</a>
									</ul>
									</li>
						<li><a href="no-sidebar.html">Index</a></li>
						<li><a href="no-sidebar.html">Industry</a></li>
					</ul>
				</nav>

			<!-- Main -->
				<div id="main-wrapper">
					<div id="main" class="container">
						<div class="row">
							<div class="12u">
								<div class="content">

									<!-- Content -->

										<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta http-equiv="content-type" content="text/html;charset=utf-8"/>
		<title>Monday.html</title>
		<style type="text/css" media="screen"><!--
			tbody, thead, tfoot, tr, td, th {
				border-style : inherit;
				border-width : inherit;
				border-color : inherit;
			}
			td {
				width : 10px;
				height : 5px;
			}
			.leftFloat {
				float : left;
			}
			.rightFloat {
				float : right;
			}
			span.char-style-override-1 {
				font-family : 'Open Sans', sans-serif;
				font-weight : 300;
				letter-spacing: 12px;
				font-style : normal;
				padding-bottom: 15px;
				font-size : 2.5em;
				color : #045292;
			}
			span.char-style-override-2 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.5em;
				font-style : normal;
				font-weight : 300;
			}
			span.char-style-override-3 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.5em;
				font-style : normal;
				font-weight : 600;
			}
			span.char-style-override-4 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 600;
			}
			span.char-style-override-5 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 300;
			}
			span.char-style-override-6 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 300;
			}
			span.char-style-override-7 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 300;
				text-transform : uppercase;
			}
				span.char-style-override-8 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1em;
				font-style : normal;
				font-weight : 300;
			}
			p.No-Paragraph-Style {
				font-family : "Minion Pro", serif;
				font-weight : normal;
				font-style : normal;
				font-size : 1em;
				text-decoration : none;
				font-variant : normal;
				line-height : 1.2;
				text-align : left;
				color : #000000;
				text-indent : 0px;
				margin : 0px;
			}
			p.para-style-override-1 {
				margin-top : 30px;
				padding-top: 12px;
				border-top : 2px solid #045292;
				text-align: justify;
			}
			p.para-style-override-2 {
				margin-top : 9px;
				color: #045292;
			}
			p.para-style-override-3 {
				margin-left: 58px;
				margin-top : 6px;
			}
			p.para-style-override-4 {
				margin-left : 55px;
				margin-right : 0px;
				margin-top : 20px;
				text-indent : -55px;
			}
			p.para-style-override-5 {
				margin-left : 55px;
				margin-top : 3px;
			}
			p.para-style-override-6 {
				margin-left : 55px;
				margin-top : 3px;
			}
			div.Basic-Text-Frame  {
			  margin-left : 0px;
			  margin-right: 0px;
			}
{
			}
		--></style>
	</head>
	</head>
	<body>
		<div id="Wednesday.html" xml:lang="en-US">
			<div class="Basic-Text-Frame">
				<p class="No-Paragraph-Style"><span class="char-style-override-1">Wednesday, July 6, 2016</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">8:00 - 9:00&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">PLENARY SESSION: WHAT RESULTS CAN WE PREDICT FOR OUR PATIENTS?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">S. Carney </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-5">522</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">8:00	WHAT OUTCOMES PATIENTS CAN EXPECT FROM SURGERY VS. MEDICAL THERAPY 523</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">T.&nbsp;Smith</span><span class="char-style-override-5"> (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">8:20	HOW WE CAN PREDICT AND IMPROVE OUR PATIENT&apos;S OUTCOMES524</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C. Hopkins </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">8:40	DOES EXTENT OF SURGERY EFFECT OUTCOMES?525</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A. Cervin </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:00 - 9:10Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">BREAK</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 29: BENIGN TUMOURS IN RHINOLOGY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Sama </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-5">526</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	IMAGING - DIFFERENTIAL DIAGNOSIS527</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">N. Freling </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	HOW TO DEAL WITH BONE TUMOURS IN THE NOSE528</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H. Dhong (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	RESPIRATORY ADENOMATOUS EPITHELIAL HAMARTOMA529</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Jankowski </span><span class="char-style-override-5">(France)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:04	INVERTED PAPILLOMA530</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">A.&nbsp;Herrera</span><span class="char-style-override-5"> (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 30: FACIAL PAIN AND HEADACHE</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">Y. Kurono </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-5">531</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	DIAGNOSIS OF FACIAL PAIN532</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-5"></span><span class="char-style-override-4">M. Setzen</span><span class="char-style-override-5"> (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	TREATMENT ALGORITHMS FOR FACIAL PAIN533</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.M.&nbsp;Agius</span><span class="char-style-override-5">, N.S.&nbsp;Jones, R.&nbsp;Muscat (Malta)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	REFERRED PAIN534</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Karlberg </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:04	SPOTTING THE NIGHTMARE535</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D. Kennedy </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 31: WHAT’S NEW IN TREATMENT OF ALLERGIC RHINITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">Å. Davidsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">536</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	OVERVIEW OF PRESENT GUIDELINES537</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J. Mullol</span><span class="char-style-override-5"> (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	COMPONENTS538</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. van Hage </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	ANTI-IgE AND CYTOKINES539</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T. Van Zele </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:04	WHAT&apos;S NEW IN IMMUNOTHERAPY OF ALLERGIC RHINITIS540</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L. Poulsen </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 32: THE BLEEDING NOSE AS A WAY OF LIFE: HHT</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">T. Kühnel </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-5">541</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	THE PATIENT542</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">W. Göran </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:25	BACKGROUND543</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A. Kjeldsen </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:40	MEDICAL TREATMENT544</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">U. Geisthoff</span><span class="char-style-override-5"> (Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:55	SURGICAL TREATMENT545</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V. Lund </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:10	TREATMENT OUTCOMES546</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G. Bachmann-Harildstad</span><span class="char-style-override-5"> (Norway)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 33: JUNIOR MEMBER SYMPOSIUM: “FACIAL PLASTICS”</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Slovick </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-5">547</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	INTRODUCTORY TALK548</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">F. Apaydin </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	INSTRUCTIONAL LECTURE549</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H.&nbsp;Saleh</span><span class="char-style-override-5"> (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	NOVEL OUTCOME MEASUREMENT TOOL OF THE NASAL VALVE SURGERY: IMAGE ANALYSIS USING ENDOSCOPIC SYSTEM FOR SMARTPHONES550</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Surda</span><span class="char-style-override-5">, A.&nbsp;Walker, S.&nbsp;Little, A.&nbsp;Toma (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:53	FUNCTIONAL RESPIRATORY IMAGING-AIDED VIRTUAL PREOPERATIVE PLANNING IN NASAL SURGERY: TOWARDS A PERSONALIZED APPROACH551</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;Ansari</span><span class="char-style-override-5">, W.&nbsp;Vos, C.&nbsp;Van Holsbeke, P.&nbsp;Lefebvre, A.L.&nbsp;Poirrier (Belgium)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:00	ASSESSMENT OF NASAL PATENCY USING BILATERAL AND UNILATERAL PEAK NASAL INSPIRATORY FLOW PRE AND POST SEPTORHINOPLASTY SURGERY552</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Kaura</span><span class="char-style-override-5">, J.&nbsp;Joseph, P.&nbsp;Andrews (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:07	CASES SUBMITTED - PANEL DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 34: THE MULTI-DISCIPLINARY TEAM IN COMPLEX RHINOLOGY  </span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">C. Georgalas </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-5">553</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	GPA554</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C. Ahlström Emanuelsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	HHT555</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">J.&nbsp;Rimmer </span><span class="char-style-override-5">(Australia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	UNITED AIRWAYS556</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Steinsvag</span><span class="char-style-override-5"> (Norway)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:04	SKULL BASE SURGERY557</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Castelnuovo </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 35: GPA AND OTHER VASCULITIS DISEASES IN THE NOSE</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">K. Snidvongs </span><span class="char-style-override-5">(Thailand)</span><span class="char-style-override-4"></span><span class="char-style-override-5">558</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	DIFFERENT TYPES OF VASCULITIS - DIFFERENTIAL DIAGNOSIS559</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;Prokopakis </span><span class="char-style-override-5">(Greece)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	RHINOLOGIC ASPECTS- INVESTIGATION/DIAGNOSIS560</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Douglas </span><span class="char-style-override-5">(New Zealand)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	TREATMENT OPTIONS561</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">O. Börjesson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:04	SURGICAL MANAGEMENT OF THE NOSE AND SINUSES IN VASCULITIS/GRANULOMATOSIS562</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Andrews</span><span class="char-style-override-5"> (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 31: RHINITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">Å. Davidsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">563</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	RICH ALLERGEN CONTENT OF THE BOVINE DANDER EXTRACT IMPROVES DETECTION OF OCCUPATIONAL RHINITIS564</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.&nbsp;Airaksinen</span><span class="char-style-override-5">, H.&nbsp;Suojalehto, I.&nbsp;Lindström, J.&nbsp;Sund, P.&nbsp;Pallasaho, A.&nbsp;Puustinen (Finland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:20	EFFECTIVENESS OF ANTILEUKOTRIENES IN THE TREATMENT OF NON-ALLERGIC EOSINOPHILIC RHINITIS565</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;De Corso</span><span class="char-style-override-5">, R.&nbsp;Anzivino, S.&nbsp;Baroni, M.&nbsp;Romanello, R.&nbsp;Cimorelli, C.&nbsp;Autilio, G.C.&nbsp;Passali, W.&nbsp;Di Nardo, C.&nbsp;De Vita, M.&nbsp;Rigante, G.&nbsp;Paludetti (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:30	INTRANASAL CORTICOSTEROIDS FOR NON-ALLERGIC RHINITIS: COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS566</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">A.&nbsp;Gevorgyan</span><span class="char-style-override-5">, C.&nbsp;Segboer, S.&nbsp;Chusakul, J.&nbsp;Kanjanaumporn, S.&nbsp;Aeumjaturapat, R.&nbsp;Reeskamp, W.&nbsp;Fokkens, K.&nbsp;Snidvongs (Canada)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:40	LOCAL ALLERGIC RHINITIS (LAR) IN JAPAN567</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Matsune</span><span class="char-style-override-5">, M.&nbsp;Ishida, N.&nbsp;Wakayama, Y.&nbsp;Yuma, Y.&nbsp;Satoshi, S.&nbsp;Kuwon, K.&nbsp;Okubo (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:50	THE EFFECT OF ALLERGIC RHINITIS ON CHOROIDAL THICKNESS568</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Yenigun</span><span class="char-style-override-5">, A.&nbsp;Elbay, B.&nbsp;Sahan, R.&nbsp;Dogan, O.&nbsp;Ozturan (Turkey)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:00	NASAL SENSITIVITY TO MUSTARD OIL AND SELF-REPORTED NASAL HYPERREACTIVITY PREDICT THE THERAPEUTIC RESPONSE OF CAPSAICIN IN IDIOPATHIC RHINITIS PATIENTS569</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.&nbsp;Van Gerven</span><span class="char-style-override-5">, Y.&nbsp;Alpizar, B.&nbsp;Steelant, E.&nbsp;Dekimpe, I.&nbsp;Kortekaas, K.&nbsp;Talavera, P.&nbsp;Hellings (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:10	EVALUATION OF NON-SELECTIVE CHEMOKINE LEVELS IN NASAL SECRETIONS OF PATIENTS WITH NON-ALLERGIC RHINITIS WITH EOSINOPHILIA SYNDROME AND PERENNIAL ALLERGIC RHINITIS570</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">A.&nbsp;Peric</span><span class="char-style-override-5">, J.&nbsp;Sotirovic, C.&nbsp;Spadijer Mirkovic, D.&nbsp;Vojvodic (Serbia)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 32: TREATMENT OF CHRONIC RHINOSINUSITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">C. von Buchwald </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span><span class="char-style-override-5">571</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	ENDOSCOPIC TRANSNASAL SPHENOIDOTOMY: THE BULLA DOWN TECHNIQUE FOR SINUS AND SKULL BASE PATHOLOGY572</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Al-Qudah</span><span class="char-style-override-5"> (Jordan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:15	ANATOMIC VARIATIONS OF THE PARANASAL SINUSES573</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Boavida</span><span class="char-style-override-5">, M.&nbsp;Menezes Peres, M.&nbsp;Gião, C.&nbsp;Adonis, F.&nbsp;Freire (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:20	DECONGESTANT USE IN SINONASAL SURGERY574</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Campbell</span><span class="char-style-override-5">, R.&nbsp;Douglas, S.&nbsp;Nair, R.&nbsp;Sacks (Australia)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:25	FAT GRAFT TRANSFER FOR THE MANAGEMENT OF CHRONIC REFRACTORY MAXILLARY SINUSITIS ( CRMS): INTRODUCING STEMM CELLS IN THE MANAGEMENT OF CRMS ?575</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B.&nbsp;Ibrahim</span><span class="char-style-override-5">, S.&nbsp;Nayan, S.&nbsp;AlRomaih, L.&nbsp;Le Taillandier de Gabory, M.&nbsp;Desrosiers (Canada)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:30	THE INCREASING INCIDENCE OF PARANASAL ORGANIZING HEMATOMA: A 20-YEAR EXPERIENCE OF 23 CASES AT A SINGLE CENTER576</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.S.&nbsp;Kim</span><span class="char-style-override-5">, K.&nbsp;Sam Hyun (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:35	CLINICAL MANIFESTATIONS OF SINONASAL HEMANGIOMA577</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Kwon</span><span class="char-style-override-5">, J.S.&nbsp;Kim (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:40	MUPIROCIN SALINE IRRIGATION AS AN ALTERNATIVE TREATMENT OPTION FOR RECURRENT CHRONIC RHINOSINUSITIS:  A RANDOMIZED CONTROLLED STUDY578</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Kwon</span><span class="char-style-override-5">, J.S.&nbsp;Kim (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:45	NASAL NEBULISATION OF TOBRAMYCIN: PRECLINICAL AND CLINICAL STUDY ON POST-OPERATIVE SUPPURATIONS IN NASAL POLYPOSIS PATIENT579</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V.&nbsp;Prulière-Escabasse</span><span class="char-style-override-5">, L.&nbsp;Vecellio, S.&nbsp;Le Guellec, P.&nbsp;Bonfils</span><span class="char-style-override-5"> (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:50	THE EFFICACY OF BALLOON DILATION IN THE FRONTAL RECESS580</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Y.&nbsp;Li</span><span class="char-style-override-5">, J.&nbsp;Li, X.&nbsp;Liu, Z.Q.&nbsp;Ma, M.&nbsp;Sha (China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:55	CYCLAMEN EUROPAEUM EXTRACT IMPROVES THE EFFECT OF ORAL ANTIBIOTICS ON CHRONIC RHINOSINUSITIS EXACERBATIONS AND RECURRENCES: A REAL-LIFE OBSERVATIONAL STUDY581</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Lopatin</span><span class="char-style-override-5">, O.&nbsp;Ivanchenko, J.&nbsp;Mullol (Russia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:00	REOPERATION POST MODIFIED ENDOSCOPIC LOTHROP PROCEDURE582</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I.&nbsp;Gwizdalska</span><span class="char-style-override-5">, A.&nbsp;Mickielewicz, H.&nbsp;Skarzynski (Poland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:05	AERODYNAMIC CRITERIA OF OSTIUM OF MAXILLARY SINUS THAT FUNCTIONS NORMALLY583</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">A.&nbsp;Nechyporenko, </span><span class="char-style-override-4">O.&nbsp;Garyuk</span><span class="char-style-override-5">, A.&nbsp;Yerokhin (Ukraine)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:10	PRIOR TURBINATE REDUCTION SURGERY AS A FACTOR INFLUENCING SLIT COMPLIENCE584</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">J.&nbsp;Tattersall, J.&nbsp;Christensen, S.&nbsp;Flanagan, </span><span class="char-style-override-4">R.&nbsp;Harvey</span><span class="char-style-override-5"> (Australia)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:15	COMPARISON OF  MEDICAL THERAPY AND BALLON DILATION SINUS SURGERY IN CHILDREN WITH CHRONIC SINUSITIS585</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Z.M.&nbsp;Xu</span><span class="char-style-override-5">, Y.H.&nbsp;Ni (China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:20	RETROMAXILLARY POSTERIOR ETHMOIDS: HERZALLAH VS. HALLER CELLSNOVEL DESCRIPTION &amp; IMPACT IN REVISION CASES586</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">I.&nbsp;Herzallah, </span><span class="char-style-override-4">F.&nbsp;Saati</span><span class="char-style-override-5">, O.&nbsp;Marglani, R.&nbsp;Simsim (Kingdom of Saudi Arabia)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 33: CHRONIC RHINOSINUSITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">L. Lundblad </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">587</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	CLINICAL ANALYSIS OF EOSINOPHILIC CHRONIC RHINOSINUSITIS588</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.&nbsp;Cho</span><span class="char-style-override-5"> (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:15	LOWER AIRWAY INFLAMMATION IN PRIMARY CARE PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS NEVER REFERRED FOR SINUS SURGERY: A PROSPECTIVE, CROSS-SECTIONAL STUDY589</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Frendø</span><span class="char-style-override-5">, K.&nbsp;Håkansson, C.&nbsp;Von Buchwald (Denmark)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:20	FRONTO-SEPTAL ROSTRUM - PREVALENCE, CLASSIFICATION AND CLINICAL IMPLICATION590</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Y.&nbsp;Golan</span><span class="char-style-override-5">, E.&nbsp;Eviatar, H.&nbsp;Gavriel (Israel)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:25	CHRONIC INVASIVE FUNGAL RHINOSINUSITIS IN IMMUNOCOMPETENT PATIENTS: THE OXFORD 5 YEAR EXPERIENCE591</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Hettige</span><span class="char-style-override-5">, T.&nbsp;Jani, A.&nbsp;Qureishi, P.&nbsp;Martinez-Devesa, R.&nbsp;Almeyda (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:30	CLUSTERING OF SYMPTOMS VS. HEALTH RELATED QUALITY OF LIFE IMPAIRMENT IN MAJOR PHENOTYPES OF CHRONIC RHINOSINUSITIS592</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.&nbsp;Kalogjera</span><span class="char-style-override-5">, T.&nbsp;Greguric, T.&nbsp;Baudoin, M.V.&nbsp;Grgic (Croatia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:35	RHINOSINUSITIS: HOW UNCINECTOMY AND BALLOON SINUPLASTY AFFECT CHRONIC INFLAMMATION OF NASAL AIRWAY. A CONTROLLED RANDOMIZED CLINICAL STUDY593</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Bizaki</span><span class="char-style-override-5">, J.&nbsp;Numminen, R.&nbsp;Taulu, M.&nbsp;Rautiainen (Finland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:40	DO EOSINOPHILIC POLYPS PREDICT OLFACTORY DYSFUNCTION AND ITS POSTOPERATIVE RECOVERY IN CHRONIC RHINOSINUSITIS ?594</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">K.H.&nbsp;Jeong, </span><span class="char-style-override-4">J.K.&nbsp;Kim</span><span class="char-style-override-5"> (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:45	FACTORS AFFECTING REVISION-RATE OF CHRONIC RHINOSINUSITIS595</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Koskinen</span><span class="char-style-override-5"> (Finland)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:50	THE VALIDITY OF NASAL ENDOSCOPY IN PATIENTS WITH CHRONIC RHINOSINUSITIS - A CLINICAL INTEROBSERVER  SURVEY596</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.L.&nbsp;Larsen</span><span class="char-style-override-5">, A.D.&nbsp;Kjeldsen, B.&nbsp;Lange, P.&nbsp;Darling (Denmark)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:55	THE CHRONIC SINUSITIS ACTION PLAN - THE PATIENT PERSPECTIVE597</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Nayan</span><span class="char-style-override-5">, M.&nbsp;Desrosiers, S.&nbsp;Kilty (Canada)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:00	INCREASED SERUM IGA LEVELS IN CHRONIC RHINOSINUSITIS598</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Nayan</span><span class="char-style-override-5">, A.&nbsp;Maniakas, F.&nbsp;Lariviere, L.&nbsp;Endam, M.&nbsp;Desrosiers (Canada)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:05	SINONASAL SYMPTOM-RELATED SLEEP DISORDERS BEFORE AND AFTER SURGERY FOR NASAL POLYPOSIS599</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.T.&nbsp;Nguyen</span><span class="char-style-override-5">, F.&nbsp;AROUS, P.&nbsp;Gallet, M.&nbsp;Felix-Ravelo, P.L.&nbsp;Nguyen-Thi, R.&nbsp;Jankowski (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:15	COMPLEX FRONTAL PNEUMOSINUS DILATANS ASSOCIATED WITH MENINGIOMA: A REPORT OF TWO CASES AND ASSOCIATED LITERATURE REVIEW600</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">S.&nbsp;Timms, </span><span class="char-style-override-4">R.&nbsp;Lakhani</span><span class="char-style-override-5">, S.&nbsp;Connor, C.&nbsp;Hopkins (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:20	A PRECLINICAL MODEL OF CHRONIC RHINOSINUSITIS601</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.Y.&nbsp;CHO</span><span class="char-style-override-5">, D.&nbsp;Skinner, C.&nbsp;MacKey, B.&nbsp;Woodworth (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">10:25 - 11:00Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">COFFEE BREAK, EXHIBITION AND POSTER VIEWING</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 36: SINONASAL MALIGNANT TUMOURS; TREATMENT OPTIONS AND OUTCOME</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">V. Lund </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-5">602</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	OVERVIEW603</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V. Lund </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:15	OLFACTORY NEUROBLASTOMA604</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"> TBA</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:30	SQUAMOUS CELL CARCINOMA605</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">N.&nbsp;Otori </span><span class="char-style-override-5">(Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:45	ADENOCARCINOMA606</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Jorissen </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	MALIGNANT MELANOMA607</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Jangard</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 37: EAFPS SESSION: THE NASAL VALVE</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Sjögren </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">608</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	PRIMARY VALVE SURGERY609</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.J.&nbsp;Tasman</span><span class="char-style-override-5"> (Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	REVISIONAL VALVE SURGERY610</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J. Sykes </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	SURGERY OF THE EXTERNAL VALVE611</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">F. Apaydin </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:54	THE STAIRSTEP GRAFT - AN INNOVATIVE TECHNIQUE IN NASAL VALVE SURGERY612</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G. Suarez </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 38: IMMUNOTHERAPY IN ALLERGIC RHINITIS – THINGS TO LEARN FOR A RHINOLOGIST?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">C. Ahlström Emanuelsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">613</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	UNDER THE SKIN?614</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Andersson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:15	UNDER THE TONGUE?615</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G. Scadding </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:30	SUBLINGUAL IMMUNOTHERAPY IN HOUSE DUST MITE? 616</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L. Cheng </span><span class="char-style-override-5">(China)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:45	PRACTICAL TIPS AND TRICKS617</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L. Poulsen </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	WHAT’S AROUND THE CORNER?618</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.O.&nbsp;Cardell</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 39: EAACI SESSION: ENVIRONMENTAL FACTOR- SCUAD</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">L. Klimek </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-5">619</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	ENVIRONMENTAL FACTORS IN CHRONIC UPPER AIRWAY DISEASE620</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V. Hox </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	OCCUPATIONAL RHINITIS: ALLERGEN EXPOSURE IN THE WORKPLACE621</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Campo Mozo</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	LOCAL ALLERGIC RHINITIS622</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C. Rondon </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:54	TREATMENT STRATEGIES IN UNCONTROLLED ALLERGIC RHINITIS623</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Moesges </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 40: ARS SESSION: POLYPS FROM HELL! WHAT TO DO FOR RECALCITRANT DISEASE?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">R. Casiano </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">624</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	AGGRESSIVE POLYP DISEASE: ARE THERE GEOGRAPHIC AND RACIAL DIFFERENCES?625</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.M. DelGaudio </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	OFFICE MANAGEMENT OF RECURRENT NASAL POLYPS. HOW MUCH CAN WE DO?626</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Hwang </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	IS THERE A ROLE FOR THE USE OF BIOLOGICS FOR RECURRENT NASAL POLYPS? WHAT IS THE EVIDENCE?627</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Kern </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:54	EXTENT OF SURGERY FOR RECURRENT NASAL POLYPS; ROLE FOR EXTENDED PROCEDURES?628</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Casiano</span><span class="char-style-override-5"> (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 41: PAEDIATRIC RHINOSINUSITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Cornet </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-5">629</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	ACUTE RHINOSINUSTIS IN CHILDREN630</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.&nbsp;Kalogjera</span><span class="char-style-override-5"> (Croatia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	IS THERE STILL AN INDICATION FOR SURGERY IN ORBITAL COMPLICATIONS TO ACUTE RHINOSINUSITIS631</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Swift</span><span class="char-style-override-5"> (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	CRS IN CHILDREN - DOES IT EXIST?632</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Westman </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:54	TREATMENT OF CRS IN CHILDREN - WHEN IS SURGERY APPROPRIATE? 633</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H. Ramadan </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 42: IMPACT OF NASAL INFLAMMATION ON …</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Ehnhage </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">634</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	HEALTH ECONOMICS635</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Setzen</span><span class="char-style-override-5"> (USA)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	QUALITY OF LIFE636</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Sahlstrand-Johnson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	OSA637</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.&nbsp;Friberg</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:54	OLFACTION638</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;Holbrook</span><span class="char-style-override-5"> (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:00&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 34: GENETICS, PHARMACOGENETICS AND TISSUE ENGINEERING</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Desrosiers </span><span class="char-style-override-5">(Canada)</span><span class="char-style-override-4"></span><span class="char-style-override-5">639</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	NASAL POLYP MUCOCILIAR DIFFERENTIATION HAS A DIFFERENTIAL GENE EXPRESSION PROFILE COMPARED TO HEALTHY NASAL MUCOSA640</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B.&nbsp;Callejas</span><span class="char-style-override-5">, G.&nbsp;Fernández, L.&nbsp;Michel, A.&nbsp;Martínez, M.&nbsp;Fuentes, I.&nbsp;Alobid, F.&nbsp;Jaume, L.&nbsp;Pujols, J.&nbsp;Roca-Ferrer, C.&nbsp;Picado, S.G.&nbsp;Kalko, J.&nbsp;Mullol (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:12	INTEGRATED ANALYSIS OF MICRORNA AND MRNA EXPRESSION PROFILES  IN THE DIFFERENTIATION OF HUMAN NASAL POLYP EPITHELIAL CELLS COMPARED TO CONTROL NASAL MUCOSA.641</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B.&nbsp;Callejas</span><span class="char-style-override-5">, F.&nbsp;Guerau, L.&nbsp;Michel, A.&nbsp;Martínez, M.&nbsp;Fuentes, I.&nbsp;Alobid, F.&nbsp;Jaume, L.&nbsp;Pujols, J.&nbsp;Roca-Ferrer, C.&nbsp;Picado, S.G.&nbsp;Kalko, J.&nbsp;Mullol (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:24	DETECTING THE BIOMARKERS OF NEURODEGENERATIVE DISEASE IN THE NOSE.642</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Gane</span><span class="char-style-override-5">, G.A.&nbsp;Gurria, D.&nbsp;Logan (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	SPLEEN TYROSINE KINASE INDUCES MUC5AC EXPRESSION IN HUMAN AIRWAY EPITHELIAL CELL643</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Y.D.&nbsp;Kim</span><span class="char-style-override-5">, H.G.&nbsp;Na, B.&nbsp;Chang Hoon, Y.S.&nbsp;Choi, S.Y.&nbsp;Song (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:48	ALTERATIONS IN NASAL EPITHELIAL TRANSCRIPTOME AFTER SUBCUTANEOUS BIRCH POLLEN IMMUNOTHERAPY644</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Toppila-Salmi</span><span class="char-style-override-5">, E.&nbsp;Terna, P.&nbsp;Mattila, S.&nbsp;Joenväärä, J.&nbsp;Renkonen, R.&nbsp;Renkonen (Finland)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 35: RHINOLOGY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">K. Toll </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">645</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	SURGICAL TREATMENT FOR EPISTAXIS646</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Costello</span><span class="char-style-override-5">, H.&nbsp;Elhassan, S.&nbsp;Quine (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:07	ESTABLISHMENT OF OLFACTORY DIAGNOSIS FOR TRADITIONAL CHINESE VERSION OF UNIVERSITY OF PENNSYLVANIA SMELL IDENTIFICATION TEST647</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.S.&nbsp;Jiang</span><span class="char-style-override-5">, K.L.&nbsp;Liang (Taiwan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:14	IMPORTANCE OF CORRECTIVE NASAL SURGERY IN OBSTRUCTIVE SLEEP APNOEA SYNDROME PATIENTS WITH CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) INTOLERANCE648</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Merma Linares</span><span class="char-style-override-5">, M.&nbsp;Gonzalez Pena, S.&nbsp;Perello Aragones, F.X.&nbsp;Aviles Jurado, M.D.&nbsp;Martinez Novoa (Spain)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:21	INTRAORAL &quot;AROUND-THE-MAXILLA&quot; ENDOSCOPIC LIGATION OF MAXILLARY ARTERY IN THE INFRATEMPORAL FOSSA: ANATOMICAL STUDY AND TECHNIQUE REVISITED. CAN WE AVOID EMBOLIZATION IN CERTAIN CASES?649</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G.&nbsp;Polev</span><span class="char-style-override-5">, D.&nbsp;Golbin, K.&nbsp;Avdeeva (Russia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:28	FEASIBILITY OF ELECTRICAL IMPEDANCE TOMOGRAPHY AS A REAL-TIME MONITORING DEVICE FOR DETECTION OF THE UPPER AIRWAY OCCLUSION650</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.W.&nbsp;Kim</span><span class="char-style-override-5">, E.J.&nbsp;Woo, T.I.&nbsp;Oh, D.&nbsp;Lee, S.Y.&nbsp;Jeon, H.J.&nbsp;Cho, Y.H.&nbsp;Joo (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:35	CORRELATION OF CENTRAL COMPONENT/ TOTAL DURATION OF MIXED APNEAS WITH DEMOGRAPHIC AND POLYSOMNOGRAPHIC DATA IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA651</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">V.&nbsp;Gungor, K.M.&nbsp;Ozcan, N.&nbsp;Yurtsever Kum, D.&nbsp;Atan, </span><span class="char-style-override-4">M.&nbsp;Ozcan</span><span class="char-style-override-5"> (Turkey)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:42	THE EFFECT OF MIXED APNEA INDEX ON POSITIVE AIRWAY PRESSURE THERAPY COMPLIANCE652</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">K.M.&nbsp;Ozcan, N.&nbsp;Yurtsever Kum, R.O.&nbsp;Kum, D.&nbsp;Atan, V.&nbsp;Gungor, </span><span class="char-style-override-4">M.&nbsp;Ozcan</span><span class="char-style-override-5"> (Turkey)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:49	THE SENSATION OF PAIN/PRESSURE IN THE FACE IN PATIENTS WITH CHRONIC RHINOSINUSITIS AND NASAL SEPTUM DEFORMITY653</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Savovic</span><span class="char-style-override-5">, L.&nbsp;Jovancevic, B.C.&nbsp;Maja, V.&nbsp;Kljajić (Serbia)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:56	CLINICAL VARIABLES AND SEVERITY PREDICTORS IN SEVERE IDIOPATHIC EPISTAXIS:  A RETROSPECTIVE REVIEW OF HOSPITALIZED PATIENTS654</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.&nbsp;Tomé</span><span class="char-style-override-5">, M.&nbsp;Canas Marques, P.&nbsp;Rocha Pereira, M.&nbsp;Alveirinho Simão, O.&nbsp;Dias (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:03	THE EFFECT OF SEPTORHINOPLASTY ON OLFACTION: A SYSTEMATIC REVIEW655</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Whitcroft</span><span class="char-style-override-5">, P.&nbsp;Andrews (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 36: NASAL SURGERY, TECHNIQUES</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Törngren </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">656</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	AUDIT OF RE-ADMISSION RATES OF OVERNIGHT STAY SEPTOPLASTY657</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H.&nbsp;Elhassan</span><span class="char-style-override-5">, N.&nbsp;Leung, T.&nbsp;Hywel, K.&nbsp;Saw, H.&nbsp;Whittet (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:05	ENDOSCOPIC FRONTAL SURGERY658</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Haruna</span><span class="char-style-override-5"> (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:10	ANTIBIOTIC IN SEPTOPLASTY659</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Haye</span><span class="char-style-override-5">, L.K.&nbsp;Døsen, M.&nbsp;TarAngen, O.&nbsp;Shiryaeva, E.&nbsp;Lingaas (Norway)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:15	FAILURE TO FOLLOW-UP APPOINTMENTS AFTER SEPTOPLASTY AND TURBINATE SURGERY660</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Hijano</span><span class="char-style-override-5">, M.&nbsp;Cantón, J.&nbsp;Fusté, M.&nbsp;Costey, J.&nbsp;Comas, J.&nbsp;Fontané (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:20	LATERAL ALOTOMY APPROACH FOR NASAL AND MIDFACIAL LESIONS661</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">G.&nbsp;Karkanis, I.&nbsp;Konstantinidis, A.&nbsp;Chatziavramidis, J.&nbsp;Constantinidis, </span><span class="char-style-override-4">Z.&nbsp;Tsinaslanidou</span><span class="char-style-override-5"> (Greece)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:25	FACTORS ASSOCIATED WITH RECURRENCE AND METASTASIS IN PRIMARY CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE PINNA – A 3 YEAR RETROSPECTIVE STUDY AND META-ANALYSIS662</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Khan</span><span class="char-style-override-5">, J.&nbsp;Stansfield, S.&nbsp;Khwaja (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:30	NASAL VALVE STABILIZATION IN EXTRACORPOREAL SEPTOPLASTY663</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;La Melia</span><span class="char-style-override-5">, T.&nbsp;Losano, G.&nbsp;Ceroni Compadretti, I.&nbsp;Tasca (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:35	COMPARISON OF ABSORBABLE AND NON-ABSORBABLE NASAL PACKING AFTER SEPTAL SURGERY.664</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Lee</span><span class="char-style-override-5">, J.H.&nbsp;Lee, J.S.&nbsp;Park (Republic of Korea)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:40	NASAL VALVE STABILIZATION IN EXTRACORPOREAL SEPTOPLASTY665</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Losano</span><span class="char-style-override-5">, I.&nbsp;Tasca, G.&nbsp;Ceroni Compadretti, Y.&nbsp;Lijdens, C.&nbsp;Boccio (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:45	TRANSSEPTAL APPROACH TO THE MODIFIED ENDOSCOPIC LOTHROP PROCEDURE666</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Nishiike</span><span class="char-style-override-5">, T.&nbsp;Imai, K.&nbsp;Oshima, H.&nbsp;Tanaka, Y.&nbsp;Tsuruta, Y.&nbsp;Tomiyama (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:50	DEFINITION AND VALIDATION OF AN ANALYTICAL SCALE OF THE NASAL DEFORMATIONS IN RHINOPLASTY667</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Radulesco</span><span class="char-style-override-5">, M.&nbsp;Achache, P.&nbsp;Martin, J.M.&nbsp;Thomassin, P.&nbsp;Dessi, M.&nbsp;Justin (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:55	ROLE OF ALPHA-TOCOPHEROL ACETATE IN MUCOSAL RESTORATION AFTER SINONASAL SURGERY668</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.&nbsp;Testa</span><span class="char-style-override-5">, G.&nbsp;Panin, A.&nbsp;Guariglia, M.&nbsp;Nunziata, F.T.&nbsp;Zappoli, G.&nbsp;Marcuccio (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	SEPTOPLASTY - ARE POPULATION DEMANDS INCREASING?669</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Costello</span><span class="char-style-override-5">, Q.&nbsp;Stuart (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:05	SUBMUCOSAL MICRODEBRIDER-ASSISTED TURBINATE REDUCTION IN RHINITIS MEDICAMENTOSA: OUR EXPERIENCE AND TECHNIQUE MODIFICATION670</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G.&nbsp;Polev</span><span class="char-style-override-5">,  Avdeeva (Russia)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">12:15 - 14:00Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">BREAK, EXHIBITION AND POSTER VIEWING</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">13:00 - 14:00&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INDUSTRY SUPPORTED SESSION</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-7">Session not included in the CME/CPD Programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-7">For Programme details please refer to the Recognition, Acknowledgements &amp; Commercial Support Section in the final programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-7"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">12:30 - 14:00&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INDUSTRY SUPPORTED SESSION </span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-7">Session not included in the CME/CPD Programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-7">For Programme details please refer to the Recognition, Acknowledgements &amp; Commercial Support Section in the final programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-7"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">13:00 - 13:45&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INDUSTRY SUPPORTED SESSION </span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-7">Session not included in the CME/CPD Programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-7">For Programme details please refer to the Recognition, Acknowledgements &amp; Commercial Support Section in the final programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-7"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:00 - 15:30&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 15: BENIGN SINONASAL TUMOURS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">R. Bhalla </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-5">671</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">E. Ooi </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">672</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">R. Kamel </span><span class="char-style-override-5">(Egypt)</span><span class="char-style-override-4"></span><span class="char-style-override-6">673</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">B. Zhou </span><span class="char-style-override-5">(China)</span><span class="char-style-override-4"></span><span class="char-style-override-6">674</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Leunig </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">675</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J. Michel </span><span class="char-style-override-5">(France)</span><span class="char-style-override-4"></span><span class="char-style-override-6">676</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J. Plzak </span><span class="char-style-override-5">(Czech Republic)</span><span class="char-style-override-4"></span><span class="char-style-override-6">677</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:00 - 15:30&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 16: EAFPS SESSION: HOW TO CORRECT A BAD RHINOPLASTY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">P. Sahlstrand-Johnson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">678</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">Y. Jang</span><span class="char-style-override-5"> (Republic of Korea)</span><span class="char-style-override-6">679</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">H. Gassner </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">680</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">F. Apaydin </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-6">681</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-6"></span><span class="char-style-override-4">P. Palma</span><span class="char-style-override-4"> </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span><span class="char-style-override-6">682</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">P. Haraldsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">683</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:00 - 15:30&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 17: STRATEGIES IN IATROGENIC, TRAUMATIC AND SPONTANEOUS CSF LEAKS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">P. Castelnuovo </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span><span class="char-style-override-5">684</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">D. Simmen </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span><span class="char-style-override-6">685</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Stamm </span><span class="char-style-override-5">(Brazil)</span><span class="char-style-override-4"></span><span class="char-style-override-6">686</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Sama </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">687</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">H. Dhong</span><span class="char-style-override-5"> (Republic of Korea)</span><span class="char-style-override-6">688</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">U. Alhadi </span><span class="char-style-override-5">(Lebanon)</span><span class="char-style-override-4"></span><span class="char-style-override-6">689</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">S. Wise </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">690</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:00 - 15:30&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 18: HOW DO YOU DEAL WITH SEPTAL PERFORATION?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">K. Steensland </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">691</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">I. Alobid </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-6">692</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">C. Rhee </span><span class="char-style-override-5">(Republic of Korea)</span><span class="char-style-override-6">693</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-7"><span class="char-style-override-6">	</span><span class="char-style-override-4">T. Woolford </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">694</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Sousa Vieira </span><span class="char-style-override-5">(Portugal)</span><span class="char-style-override-6">695</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">M. Naraghi </span><span class="char-style-override-5">(Iran)</span><span class="char-style-override-4"></span><span class="char-style-override-6">696</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">N. Keles </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-6">697</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:00 - 15:30&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 19: MANAGING  SCUAD PATIENTS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">S. Steinsvag </span><span class="char-style-override-5">(Norway)</span><span class="char-style-override-4"></span><span class="char-style-override-5">698</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">H. Kawauchi </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-6">699</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J. Mullol </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span><span class="char-style-override-6">700</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J. Bretschneider </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-6">701</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">P. Hwang </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">702</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">L. Rudmik </span><span class="char-style-override-5">(Canada)</span><span class="char-style-override-4"></span><span class="char-style-override-6">703</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">S. Vlaminck </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-6">704</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:00 - 15:30&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 20: EAACI SESSION: CASES FROM THE IMMUNOTHERAPY – WHEN IT WORKED AND WHEN IT DID NOT</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">R. Moesges </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-5">705</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">H. Kariyawasam </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">706</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">Å. Davidsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">707</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">M. Rudenko </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">708</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J. Gosepath </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">709</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">L. Cheng </span><span class="char-style-override-5">(China)</span><span class="char-style-override-4"></span><span class="char-style-override-6">710</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:00 - 15:30&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 37: ENDOSCOPIC SURGERY OF SKULL BASE TUMOURS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">T. Van Zele </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-5">711</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:00	THE ROLE OF ENDONASAL ENDOSCOPIC APPROACHES IN MANAGEMENT OF SINONASAL AND INFRATEMPORAL FOSSA SCHWANNOMAS712</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H.&nbsp;Basak</span><span class="char-style-override-5">, S.&nbsp;Beton, G.&nbsp;Kahilogullari, S.&nbsp;Mulazımoglu, B.&nbsp;Kucuk, I.&nbsp;Yorulmaz, H.&nbsp;Tuna, C.&nbsp;Meco (Turkey)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:09	A COST EFFECTIVE DELIVERY SYSTEM FOR FLOSEAL® DURING TRANSNASAL ENDOSCOPIC BRAIN SURGERY713</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Y.&nbsp;Brand</span><span class="char-style-override-5">, V.&nbsp;Narayanan, N.&nbsp;Prepageran, V.&nbsp;Waran (Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:18	INVERTED PAPILLOMA: RETROSPECTIVE STUDY IN A TERTIARY CENTER714</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Eloy</span><span class="char-style-override-5">, G.&nbsp;Heylen (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:27	CAVERNOUS HAEMANGIOMAS OF THE MAXILLARY SINUS OPERATED SUCCESSFULLY WITH AN ENDONASAL APPROACH; CASE SERIES715</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Eloy</span><span class="char-style-override-5">, N.&nbsp;Terlinden (Belgium)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:36	OUTCOME AND PERIOPERATIVE COMPLICATIONS OF ENDOSCOPIC VS. OPEN CRANIOFACIAL SURGERY APPROACHES FOR RESECTION OF SINUNASAL MALIGNANCIES716</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.&nbsp;Hagemann</span><span class="char-style-override-5">, S.&nbsp;Helling, C.&nbsp;Betz (Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:45	PROGNOSTIC VALUE OF TUMOR CLASSIFICATION IN PATIENTS WITH SINONASAL MUCOSAL MELANOMA717</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Houette </span><span class="char-style-override-5">(France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:54	COMPARISON OF ANTERIOR ENDOSCOPIC TRANSNASAL APPROACH AND LATERAL MICROSURGICAL APPROACH TO THE JUGULAR FORAMEN: AN ANATOMICAL STUDY718</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.F.&nbsp;Liu</span><span class="char-style-override-5">, D.&nbsp;Yang, J.C.&nbsp;Fernandez-Miranda, P.A.&nbsp;Gardner, B.E.&nbsp;Hirsch, C.H.&nbsp;Snyderman (China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:03	SINONASAL ADENOCARCINOMAS: EXPERIENCE OF LISBON ONCOLOGY INSTITUTE BETWEEN 2000 AND 2014719</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I.&nbsp;Moura</span><span class="char-style-override-5">, C.&nbsp;Anjo, J.&nbsp;Colaço, T.&nbsp;Carvalho, R.&nbsp;Pacheco, P.&nbsp;Montalvão, M.&nbsp;Magalhães (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:12	PERIORBITAL SUSPENSION FOR MANAGEMENT OF FAR LATERAL FRONTAL SINUS LESIONS720</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Meco</span><span class="char-style-override-5">, S.&nbsp;Beton, H.&nbsp;Basak, S.&nbsp;Mulazimoglu, H.&nbsp;Guliyev, B.&nbsp;Kucuk, I.&nbsp;Yorulmaz</span><span class="char-style-override-5"> (Turkey)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:21	ENDOSCOPIC NASOPHARYNGECTOMY: HONG KONG EXPERIENCE721</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.Y.D.&nbsp;Lee</span><span class="char-style-override-5"> (Hong Kong- China)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:00 - 15:30&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 38: RHINOLOGY MISCELLANEOUS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">R. Vedantam </span><span class="char-style-override-5">(India)</span><span class="char-style-override-4"></span><span class="char-style-override-5">722</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:00	ROBOTICS723</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Caversaccio</span><span class="char-style-override-5"> (Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:09	PEDIATRIC NASOPHARYNGEAL MALIGNANT TUMORS: CLINICAL PRESENTATION AND SURVIVALS ANALYSIS IN 28 PATIENTS724</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I.&nbsp;Delgado</span><span class="char-style-override-5">, I.M.&nbsp;Moura, M.&nbsp;Menezes Peres, P.&nbsp;Montalvão, M.&nbsp;Magalhães (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:18	EPISTAXIS: HOW HELPFUL ARE ONLINE MEDICAL RESOURCES FOR PATIENTS?725</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H.&nbsp;Lancer</span><span class="char-style-override-5">, R.&nbsp;Lakhani, D.&nbsp;Roberts (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:27	GENOMIC ANALYSIS OF OLFACTORY NEUROBLASTOMA AND ESTABLISHMENT OF NOVEL OLFACTORY NEUROBLASTOMA CELL LINE MODELS726</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Lechner</span><span class="char-style-override-5">, T.&nbsp;Fenton, C.&nbsp;Kranjec, J.&nbsp;Herrero, S.&nbsp;Henderson, L.&nbsp;Williams, N.&nbsp;Pillay, D.&nbsp;Ho, M.&nbsp;Forster, A.&nbsp;Jay, W.&nbsp;Yarbrough, D.&nbsp;Howard, V.&nbsp;Lund (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:36	SNOT-22 REVEALS LATENT PATHOLOGY IN YOUNG ADULTS727</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;Prokopakis</span><span class="char-style-override-5">, A.&nbsp;Milioni, I.&nbsp;Lymperidis, A.&nbsp;Kaprana, S.&nbsp;Velegrakis, G.&nbsp;Velegrakis (Greece)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:45	CORRELATION STUDY ON THE SYMPTOM SCALES BETWEEN CHRONIC RHINOSINUSITIS AND LARYNGOPHARYNGEAL REFLUX728</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.&nbsp;Ren</span><span class="char-style-override-5">, Y.&nbsp;Zhao, X.&nbsp;Ren, J.&nbsp;Du, L.&nbsp;Lei (China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:54	PROGNOSTIC BIOMARKERS AND MOLECULAR FEATURES OF P16/HPV POSITIVE NEOPLASIA OF THE NOSE AND PARANASAL SINUSES: A SYSTEMATIC REVIEW729</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.L.&nbsp;Sacks</span><span class="char-style-override-5">, J.&nbsp;Christensen, R.&nbsp;Sacks, P.&nbsp;Earls, R.&nbsp;Gallagher, R.&nbsp;Harvey (Australia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:03	POSTOPERATIVE CARE OF PATIENTS AFTER FESS WITH THE USE OF MASTIC OIL AND OLIVE OIL. A MEDITERRANEAN APPROACH730</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Sarafidou</span><span class="char-style-override-5">, I.&nbsp;Konstantinidis, A.&nbsp;Chatziavramidis, J.&nbsp;Constantinidis (Greece)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:12	RISING INCIDENCE OF HEAD AND NECK MUCOSAL MELANOMA IN AUSTRALIA731</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V.&nbsp;Sarju</span><span class="char-style-override-5">, D.&nbsp;Youssef, A.&nbsp;Cervin (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:21	A META-ANALYSIS OF SURVIVAL FACTORS IN RHINO-ORBITAL-CEREBRAL MUCORMYCOSIS732</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Vaughan</span><span class="char-style-override-5">, A.&nbsp;Bartolo, S.C.&nbsp;Leong (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:00 - 15:30&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 39: RHINOLOGY MISCELLANEOUS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">D. Vicheva </span><span class="char-style-override-5">(Bulgaria)</span><span class="char-style-override-4"></span><span class="char-style-override-5">733</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:00	CLINICAL FINDINGS OF SINONASAL FIBRO-OSSEOUS LESIONS EXCEPT OSTEOMA734</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.K.&nbsp;Chung</span><span class="char-style-override-5">, J.&nbsp;Choi, G.&nbsp;Ryu, H.J.&nbsp;Dhong, H.Y.&nbsp;Kim, S.D.&nbsp;Hong (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:09	A DECADE OF RHINOLOGY IN SAINT LUCIA735</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Rizan</span><span class="char-style-override-5">, H.&nbsp;Elhassan (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:18	NASAL MUCOSA MELANOMAS IN IPOLFG (1995-2010)736</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Gabriel</span><span class="char-style-override-5">, A.&nbsp;Jardim, P.&nbsp;Campelo, B.&nbsp;Araújo, R.&nbsp;Fino, P.&nbsp;Montalvão, M.&nbsp;Magalhães (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:27	EXOPHYTIC SINONASAL PAPILLOMAS AND NASAL FLORID PAPILLOMATOSIS: A RETROSPECTIVE STUDY737</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Glatre</span><span class="char-style-override-5">, E.&nbsp;Bequignon, I.&nbsp;Abd Alsamad, V.&nbsp;Pruliere-Escabasse, A.&nbsp;Gauthier, L.&nbsp;Brugel, A.&nbsp;Coste, H.&nbsp;De Kermadec (France)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:36	THREE-DIMENSIONAL COMPUTED TOMOGRAPHIC STUDY OF THE SUPREME NASAL TURBINATE738</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Gotlib</span><span class="char-style-override-5">, M.&nbsp;Kuźmińska, K.&nbsp;Niemczyk (Poland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:45	THE ONODI CELL AND OPTIC CANAL ASSESSED IN PARANASAL SINUS CT IN ASIAN NOSE739</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Kitamura</span><span class="char-style-override-5">, T.&nbsp;Shikina, M.&nbsp;Hayama, Y.&nbsp;Yamamura, H.&nbsp;Nishimura, S.&nbsp;Nishiike (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:54	THE BURDEN OF RHINOLOGIC DISEASE740</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Lundberg</span><span class="char-style-override-5">, M.&nbsp;Ylitalo-Heikkilä, R.P.&nbsp;Roine, H.&nbsp;Sintonen, P.&nbsp;Virkkula, M.&nbsp;Hytönen (Finland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:03	ANALYSIS OF ADULT ENDOSCOPIC SINUS SURGERY OPERATIVE FLOW: OPPORTUNITIES FOR IMPROVED SAFETY &amp; EFFICIENCY741</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.&nbsp;Ramakrishna</span><span class="char-style-override-5">, D.&nbsp;Sommer, S.&nbsp;Arbabtafti (Canada)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:12	RHINOLOGIST-BEWARE-NOT ALL NASAL RESISTANCE VALUES ARE THE SAME! COMPARISON OF THE CLASSIC AND BROMS METHOD IN RHINOMANOMETRY USING NOSE MODELS742</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.H.&nbsp;Wong</span><span class="char-style-override-5">, R.&nbsp;Eccles (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:21	CHRONIC MAXILLARY ATELECTASIS AND SILENT SINUS SYNDROME: 2 SHADES OF THE SAME ENTITY. CASES SERIES743</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Eloy</span><span class="char-style-override-5">, M.&nbsp;Horoi, H.&nbsp;Sergio, P.&nbsp;Rombaux, C.&nbsp;De Dorlodot (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">15:30 - 16:00Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">COFFEE BREAK, EXHIBITION AND POSTER VIEWING</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">15:30 - 16:00&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ERS GENERAL ASSEMBLY</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 21: HOW TO MANAGE INVERTED PAPILLOMA</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J. Shi </span><span class="char-style-override-5">(China)</span><span class="char-style-override-4"></span><span class="char-style-override-6">744</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 22: IgG4 SYNDROME </span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">M. Andersson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6"> 745</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 23: NASAL TRAUMA IN CHILDREN</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">I. Tasca </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span><span class="char-style-override-6">746</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">DEBATE: SYSTEMIC CORTICOSTEROIDS – OVERUSE OR UNDERUSE?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">V. Lund </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-5">747</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	SYSTEMIC CORTICOSTEROIDS - OVERUSE 748</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D. Lal </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	SYSTEMIC CORTICOSTEROIDS - UNDERUSE749</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Holmstrom </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">DEBATE: ILIT – IT WORKS OR NOT?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Westman </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">750</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	ILIT - IT WORKS 751</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L. Cardell </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	ILIT - IT DOES NOT WORK752</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L. Poulsen </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 24: HOW TO DILATE THE SINUSES WITH BALLOONS?</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">C. Hopkins </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">753</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 25: HOW TO CHOOSE PATIENTS FOR IMMUNOTHERAPY</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">G. Scadding </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">754</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 40: PATHOPHYSIOLOGY OF CRS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">B. Marple </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">755</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:00	THE FUNGI ON SINONASAL MUCOSA: NORMAL CONTENT OF MICROBIOME OR SILENT TREAT?756</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Barac</span><span class="char-style-override-5">, M.&nbsp;Pekmezovic, A.&nbsp;Ema, S.&nbsp;Rajica, V.&nbsp;Tomic Spiric (Serbia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:05	PARANASAL SINUSES ROLE A NEW MICROBIOME BASED THEORY757</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I.&nbsp;Braverman</span><span class="char-style-override-5">, A.&nbsp;Gemer (Israel)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:10	HISTOLOGICAL ANALYSIS OF NASAL POLYPOSIS IN DIFFERENT CLINICAL MANIFESTATIONS758</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">L.&nbsp;Mohana, I.&nbsp;Hazboun, </span><span class="char-style-override-4">L.&nbsp;Serrano</span><span class="char-style-override-5">, A.&nbsp;Altemani, R.&nbsp;Gusmão, E.&nbsp;Sakano (Brazil)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:15	MICROBIOME AND CULTURE BASED ANALYSIS OF DIFFERENT TYPES OF CHRONIC RHINOSINUSITIS VERSUS HEALTHY SINUS MUCOSA759</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B.&nbsp;Olzowy</span><span class="char-style-override-5">, K.&nbsp;Koeller, D.&nbsp;Herlemann, T.&nbsp;Schuldt, E.&nbsp;Guder, A.&nbsp;Ovari, B.&nbsp;Kreikemeyer (Germany)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:20	IMMUNOPATHOLOGIC CHARACTERISTICS OF VARIOUS TYPE OF KOREAN NASAL POLYPS760</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Shin</span><span class="char-style-override-5">, M.K.&nbsp;Ye, H.S.&nbsp;Jin, S.H.&nbsp;Kang (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:30	THE INDUCTION OF IL-33 IN THE SINUS EPITHELIUM AND ITS INFLUENCE ON T-HELPER CELL RESPONSES761</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Soyka</span><span class="char-style-override-5">, D.&nbsp;Holzmann, C.&nbsp;Akdis, T.&nbsp;Eiwegger (Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:35	ROLE OF GROUP 2 INNATE LYMPHOID CELLS IN THE PATHOGENESIS OF EOSINOPHILIC CHRONIC RHINOSINUSITIS762</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I.&nbsp;Tojima</span><span class="char-style-override-5">, H.&nbsp;Kouzaki, S.&nbsp;Shimizu, T.&nbsp;Ogawa, M.&nbsp;Arikata, T.&nbsp;Shimizu (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:40	THROMBOXANE A2 REGULATES CXCL1 AND CXCL8 CHEMOKINE EXPRESSION IN THE NASAL MUCOSA-DERIVED FIBROBLASTS OF CHRONIC RHINOSINUSITIS PATIENTS763</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Y.J.&nbsp;Tsai </span><span class="char-style-override-5">(Taiwan)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 41: PEDIATRIC RHINOLOGY AND ALLERGIC RHINITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">C. Rondon </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span><span class="char-style-override-5">764</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:00	POSITIVITY RATES FOR COMMON ANTIGENS USING IN-VITRO TESTING765</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Benninger</span><span class="char-style-override-5">, T.&nbsp;Daly, K.&nbsp;Grafmiller, M.&nbsp;Strohl (USA)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:07	EFFECTS OF ORAL BRONCHODILATOR ON TRACHEAL SMOOTH MUSCLE IN PATIENTS WITH ALLERGIC RHINITIS AND ASTHMA766</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.Y.L.&nbsp;Chou</span><span class="char-style-override-5">, H.W.&nbsp;Wang (Taiwan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:14	CAN MOMETASONE FUROATE NASAL SPRAY CANCEL SURGERY IN CHILDREN WITH INDICATION FOR ADENOIDECTOMY?767</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">G.&nbsp;Karkanis, E.&nbsp;Tsakiropoulou, I.&nbsp;Konstantinidis, A.&nbsp;Chatziavramidis, J.&nbsp;Constantinidis, </span><span class="char-style-override-4">Z.&nbsp;Tsinaslanidou</span><span class="char-style-override-5"> (Greece)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:21	SILENT SINUS SYNDROME IN CHILDREN (CASE REPORT)768</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">E.&nbsp;Latysheva, </span><span class="char-style-override-4">Y.&nbsp;Rusetsky</span><span class="char-style-override-5">, S.&nbsp;Alekseenko, U.&nbsp;Malyavina (Russia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:28	SWINGING DOOR FLAP TECHNIQUE FOR ENDOSCOPIC TRANSEPTAL REPAIR OF BILATERAL CHOANAL ATRESIA769</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Y.&nbsp;Nour</span><span class="char-style-override-5"> (Egypt)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:35	CONGENITAL PYRIFORM APERTURE STENOSIS: A RARE CAUSE OF NASAL OBSTRUCTION IN NEONATES770</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">A.&nbsp;Jardim</span><span class="char-style-override-5">, A.&nbsp;Marinho, J.&nbsp;Subtil, J.P.&nbsp;Araújo, J.&nbsp;Saraiva (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:00 - 16:45&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 42: ORBIT AND LACRIMAL SYSTEM</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Lopatin </span><span class="char-style-override-5">(Russia)</span><span class="char-style-override-4"></span><span class="char-style-override-5">771</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:00	ORBIT DECOMPRESSION IN THE TREATMENT OF GRAVES’ ORBITOPATHY: THE ADDED VALUE OF THE THIRD WALL ORBITOTOMY IN PROPTOSIS REDUCTION772</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Calha</span><span class="char-style-override-5">, S.&nbsp;Agostinho, P.&nbsp;Borges Dinis (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:05	ENDOSCOPIC DACRYOCYSTORHINOSTOMY WITH AND WITHOUT SILICONE INTUBATION: 4 YEARS RETROSPECTIVE STUDY773</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Dehgani Mobaraki</span><span class="char-style-override-5">, F.&nbsp;Longari, A.L.&nbsp;Ricci, R.&nbsp;Lapenna, C.&nbsp;Cagini, G.&nbsp;Ricci (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:10	ORBITAL COMPLICATIONS OF RHINOSINUSITIS IN THE  ADULT POPULATION774</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Elmograbi</span><span class="char-style-override-5">, A.&nbsp;Ritter, E.&nbsp;Soudry (Israel)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:15	360 DEGREES SURGICAL APPROACH TO THE ORBIT: PERSONAL CONSIDERATIONS775</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">F.R.&nbsp;Fiorini</span><span class="char-style-override-5">, P.&nbsp;Castelnuovo, M.&nbsp;Turri-Zanoni, G.&nbsp;Fiacchini, L.&nbsp;Cristofani Mencacci, P.&nbsp;Battaglia, D.&nbsp;Locatelli, P.&nbsp;Herman, S.&nbsp;Sellari-Franceschini, I.&nbsp;Dallan (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:20	ENDOSCOPIC DACRYOCYSTORHINOSTOMY IN PROXIMAL OBSTRUCTIONS OF THE NASOLACRIMAL SYSTEM776</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.R.&nbsp;Lameiras</span><span class="char-style-override-5">, J.&nbsp;Pimentel, V.&nbsp;Oliveira, D.&nbsp;Silva, P.&nbsp;Escada (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:25	TRANSCANALICULAR DIODE LASER-ASSISTED ENDOSCOPIC DACRYOCYSTORHINOSTOMY – OUR EXPERIENCE777</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Menezes Peres</span><span class="char-style-override-5">, R.&nbsp;Pacheco, J.&nbsp;Prata, T.&nbsp;Gouveia, P.&nbsp;Sousa, P.&nbsp;Mouro, J.&nbsp;Olias (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:30	IMPACT OF ENDOSCOPIC DACRYOCYSTORHINOSTOMY ON SINONASAL QUALITY OF LIFE778</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Miyake</span><span class="char-style-override-5">, L.&nbsp;Gregorio, S.&nbsp;Freitag, D.&nbsp;Lefebvre, S.&nbsp;Gray, E.&nbsp;Holbrook, B.&nbsp;Bleier (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:35	RECONSTRUCTION OF BLOWOUT FRACTURES OF INFEROMEDIAL WALLS779</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Takabayashi</span><span class="char-style-override-5">, M.&nbsp;Nagamine, T.&nbsp;Fujita (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:40	THE PRELACRIMAL APPROACH FOR THE REPAIR OF ORBITAL FLOOR FRACTURES780</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V.&nbsp;Vielsmeier</span><span class="char-style-override-5">, H.&nbsp;Jägle, T.&nbsp;Kühnel (Germany)</span></p>
			</div>
		</div>
	</body>
</html>

								</div>
							</div>
						</div>
						<div class="row 200%">
							<div class="12u">

								<!-- Features -->
									<section class="box features">
										<h2 class="major"><span>A Major Heading</span></h2>
										<div>
											<div class="row">
												<div class="3u 12u(mobile)">

													<!-- Feature -->
														<section class="box feature">
															<a href="#" class="image featured"><img src="images/pic01.jpg" alt="" /></a>
															<h3><a href="#">A Subheading</a></h3>
															<p>
																Phasellus quam turpis, feugiat sit amet ornare in, a hendrerit in
																lectus dolore. Praesent semper mod quis eget sed etiam eu ante risus.
															</p>
														</section>

												</div>
												<div class="3u 12u(mobile)">

													<!-- Feature -->
														<section class="box feature">
															<a href="#" class="image featured"><img src="images/pic02.jpg" alt="" /></a>
															<h3><a href="#">Another Subheading</a></h3>
															<p>
																Phasellus quam turpis, feugiat sit amet ornare in, a hendrerit in
																lectus dolore. Praesent semper mod quis eget sed etiam eu ante risus.
															</p>
														</section>

												</div>
												<div class="3u 12u(mobile)">

													<!-- Feature -->
														<section class="box feature">
															<a href="#" class="image featured"><img src="images/pic03.jpg" alt="" /></a>
															<h3><a href="#">And Another</a></h3>
															<p>
																Phasellus quam turpis, feugiat sit amet ornare in, a hendrerit in
																lectus dolore. Praesent semper mod quis eget sed etiam eu ante risus.
															</p>
														</section>

												</div>
												<div class="3u 12u(mobile)">

													<!-- Feature -->
														<section class="box feature">
															<a href="#" class="image featured"><img src="images/pic04.jpg" alt="" /></a>
															<h3><a href="#">And One More</a></h3>
															<p>
																Phasellus quam turpis, feugiat sit amet ornare in, a hendrerit in
																lectus dolore. Praesent semper mod quis eget sed etiam eu ante risus.
															</p>
														</section>

												</div>
											</div>
											<div class="row">
												<div class="12u">
													<ul class="actions">
														<li><a href="#" class="button big">Do Something</a></li>
														<li><a href="#" class="button alt big">Think About It</a></li>
													</ul>
												</div>
											</div>
										</div>
									</section>

							</div>
						</div>
					</div>
				</div>

			<!-- Footer -->
				<footer id="footer" class="container">
					<div class="row 200%">
						<div class="12u">

							<!-- About -->
								<section>
									<h2 class="major"><span>What's this about?</span></h2>
									<p>
										This is <strong>TXT</strong>, yet another free responsive site template designed by
										<a href="http://twitter.com/ajlkn">AJ</a> for <a href="http://html5up.net">HTML5 UP</a>. It's released under the
										<a href="http://html5up.net/license/">Creative Commons Attribution</a> license so feel free to use it for
										whatever you're working on (personal or commercial), just be sure to give us credit for the design.
										That's basically it :)
									</p>
								</section>

						</div>
					</div>
					<div class="row 200%">
						<div class="12u">

							<!-- Contact -->
								<section>
									<h2 class="major"><span>Get in touch</span></h2>
									<ul class="contact">
										<li><a class="icon fa-facebook" href="#"><span class="label">Facebook</span></a></li>
										<li><a class="icon fa-twitter" href="#"><span class="label">Twitter</span></a></li>
										<li><a class="icon fa-instagram" href="#"><span class="label">Instagram</span></a></li>
										<li><a class="icon fa-dribbble" href="#"><span class="label">Dribbble</span></a></li>
										<li><a class="icon fa-google-plus" href="#"><span class="label">Google+</span></a></li>
									</ul>
								</section>

						</div>
					</div>

					<!-- Copyright -->
						<div id="copyright">
							<ul class="menu">
								<li>&copy; Untitled. All rights reserved</li><li>Design: <a href="http://html5up.net">HTML5 UP</a></li>
							</ul>
						</div>

				</footer>

		</div>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/jquery.dropotron.min.js"></script>
			<script src="assets/js/skel.min.js"></script>
			<script src="assets/js/skel-viewport.min.js"></script>
			<script src="assets/js/util.js"></script>
			<!--[if lte IE 8]><script src="assets/js/ie/respond.min.js"></script><![endif]-->
			<script src="assets/js/main.js"></script>

	</body>
</html>